Asian Spectator


The Times

.

Josh Ferris and Justine Guerard Triumph at the 32nd Laguna Phuket Triathlon, Asia’s Longest-Running Triathlon

Australia’s Ferris and France’s Guerard conquer Phuket’s iconic resort racecourse, as international athletes battle for USD 20,000 in prize money.PHUKET, THAILAND – Media OutR...

Vinhomes' 6,200-Hectare Ha Long Bay Project: Evolving the Concept of Urban Scale

HA LONG, VIETNAM - Media OutReach Newswire - 4 August 2026 - Vinhomes has outlined the master plan for Vinhomes Global Gate Ha Long, an integrated urban development spanning approximately 6...

GARP Names Andrew Lo Risk Manager of the Year

NEW YORK and JERSEY CITY, N.J. and CAMBRIDGE, Mass., Feb. 22, 2018 /PRNewswire/ -- -- MIT Sloan School finance professor is honored for his extensive and distinguished academic work and cont...

Christmasland in New Taipei City: Four Must-Visit Zones Full of Magical Charm

TAIPEI, TAIWAN - Media OutReach Newswire - 2 December 2024 - Marking its 14th year, the 2024 Christmasland in New Taipei City makes a dazzling spectacle of magic. This year's highlights inc...

China's Leading Dairy Company Yili Buys Thailand's Largest Loc...

BANGKOK, Thailand, Nov. 30, 2018 /Xinhua-AsiaNet/-- Yili Group held a grand signing ceremony in Bangkok, Thailand on November 29th to officially buy Chomthana, which is the largest domestic ...

Google Hong Kong Launches Google Career Certificates Program 2023

New edition introduces an enriched suite of training programs, career coaching powered by TalentLabs, and a dedicated job board in collaboration with CPJobs Google Hong Kong is d...

TUMI Recruits Elite Footballer Son Heung-Min to Launch the Next Generation of Alpha Bravo

HONG KONG SAR - Media OutReach - 27 January 2022 - TUMI launches the latest evolution of its iconic Alpha Bravo collection with celebrated international footballer, Son Heung-Min. ...

Another Successful U.S. Immigration Fund EB-5 Investment Repaid

JUPITER, Fla., Oct. 28, 2022 /PRNewswireAsiaNet/ -- U.S. Immigration Fund( https://c212.net/c/link/?t=0&l=en&o=3691271-1&h=1889540361&u=https%3A%2F%2Fvisaeb-5.com%2F&a=U...

BLUE BOTTLE COFFEE Commits to Carbon Neutrality by 2024

HONG KONG SAR - Media OutReach - 23 September 2021 - Blue Bottle Coffee announced its commitment to achieve carbon neutrality by 2024. This extends to the entire brand, in the...

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

TOKYO, Dec 5, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "eribulin") will be presented during the 42nd San Antonio Breast Cancer Symposium (SABCS2019). The symposium will be held from December 10 through 14, 2019, in San Antonio, Texas in the United States.

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

A total of five poster presentations will be given at this year's SABCS including the study results evaluating absolute lymphocyte count at the baseline with eribulin as a predictor of overall survival from the post-hoc analysis of two Phase III clinical studies of eribulin in patients with advanced or metastatic breast cancer.Eisai positions oncology as a key therapeutic area, and is aiming to discover revolutionary new medicines with the potential to cure cancer. Eisai will continue to create innovation in the development of new drugs based on cutting-edge cancer research, as it seeks to contribute further to addressing the diverse needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare providers.

About Eisai

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.

For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.

Contact:Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegaluk casinos not on gamstophttps://www.capitolcitycinema.org/güvenilir bahis siteleriStreamEastStreamEastjojobet